Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9850
+0.2582 (35.53%)
At close: Oct 23, 2026, 4:00 PM EDT
0.9800
-0.0050 (-0.51%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $42.85 million as of October 23, 2026. It is the 31,240th most valuable company in the world and the 4,715th biggest in the United States. Its market cap has decreased by 50.39% in one year.
Market Cap
42.85M
Enterprise Value
42.70M
1-Year Change
-50.39%
Global Rank
Country Rank
#4,715 United States
Category
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $42.85M, an increase of 2,310.29%. That is a compound annual growth rate of 120.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 42.85M | -27.28% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 45.60M |
| Mereo BioPharma Group | 44.98M |
| Kalaris Therapeutics | 44.52M |
| Hyperion DeFi | 43.51M |
| Biomea Fusion | 43.50M |
| Adicet Bio | 42.95M |
| Annovis Bio | 42.58M |
| Serina Therapeutics | 41.91M |